Whole-brain blood flow and oxygen metabolism in the rat after halothane anesthesia.

Acta Anaesthesiologica Scandinavica
A Gjedde, B Hindfelt

Abstract

A recent modification of the Kety-Schmidt wash-out technique for 133xenon was used to measure whole-brain blood flow (CBF) and oxygen consumption (CMRO2) 1 to 4 hours after termination of halothane anesthesia in 15 Wistar rats. In this 3-hour experimental period, mean CBF and CMRO2 were reduced to 29 and 43% of control values, respectively. CBF and CMRO2 determined at the beginning and end of the experimental period were not significantly different from each other. Cerebral venous O2 tension was significantly higher than in the control group, supporting recent suggestions of a primary, intrinsic effect of halothane on the homeostatic control of this variable. It is concluded that halothane is not useful for cerebral metabolic studies in the rat.

References

Jul 1, 1975·The American Journal of Physiology·A GjeddeF Plum
Feb 1, 1972·Anesthesiology·C Y Shim, N B Andersen
Sep 1, 1974·Acta Physiologica Scandinavica·B Nilsson
Dec 1, 1974·The American Journal of Physiology·D C HowseF Plum
Jul 1, 1972·Physiological Reviews·E Betz
Dec 1, 1973·Anesthesiology·A L Smith
May 1, 1974·Journal of Applied Physiology·E P SteffeyE S Munson
Jan 1, 1972·Progress in Brain Research·J C de Valois, J P Peperkamp
Jul 1, 1971·British Journal of Anaesthesia·J D Michenfelder, R A Theye
Nov 1, 1968·Anesthesiology·R A Theye, J D Michenfelder
Nov 1, 1968·Anesthesiology·R A Theye, J D Michenfelder
Jul 1, 1964·Journal of Applied Physiology·S C ALEXANDERM BEHAR

❮ Previous
Next ❯

Citations

Jun 1, 1977·Annals of Neurology·M D GinsbergM Reivich
Apr 25, 1978·Pflügers Archiv : European journal of physiology·E Betz, M Csornai
Dec 1, 1980·Pflügers Archiv : European journal of physiology·E Siemkowicz
Feb 1, 1990·Journal of Bioenergetics and Biomembranes·C K KurupA J Dutka
Feb 1, 1979·Neurochemical Research·M Pollay, A Stevens
Jan 1, 1976·Acta Anaesthesiologica Scandinavica·L BerntmanB K Siesjö
Jul 1, 1977·Acta Physiologica Scandinavica·A GjeddeJ J Caronna
Jul 10, 2010·Journal of Biomedical Optics·Turgut DurduranDaniel J Licht
Apr 1, 1986·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·W D DietrichB D Watson
Mar 1, 1976·Acta Neurologica Scandinavica·B Hindfelt, O Nilsson
Jan 1, 1980·Stroke; a Journal of Cerebral Circulation·R W HortonB S Meldrum
Aug 1, 1980·Acta Physiologica Scandinavica·M Beausang-Linder, E Hultcrantz
Jul 1, 1976·Acta Physiologica Scandinavica·L Edvinsson, R Sercombe
Oct 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·C S HolmesT Yamada
Sep 1, 1978·Biulleten' eksperimental'noĭ biologii i meditsiny·G I Mchedlishvili, L G Ormotsadze
Jun 1, 1977·Biulleten' eksperimental'noĭ biologii i meditsiny·G I Mchedlishvili, L G Ormotsadze
Dec 31, 1976·Archiv für Psychiatrie und Nervenkrankheiten·A Brun, L Gustafson
Dec 1, 1987·Archives internationales de physiologie et de biochimie·G De Ley, I Leusen
Oct 31, 2000·The Journal of Comparative Neurology·L A Ligon, O Steward
Apr 9, 2021·Journal of Applied Physiology·Otto M HenriksenEgill Rostrup

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.